MRI features in differentiating mucosal high-grade neoplasia from early invasive squamous cell cancer of the esophagus
- PMID: 32086576
- DOI: 10.1007/s00330-020-06716-w
MRI features in differentiating mucosal high-grade neoplasia from early invasive squamous cell cancer of the esophagus
Abstract
Objectives: To evaluate the diagnostic accuracy of unenhanced and contrast-enhanced MRI in the differentiation of mucosal high-grade neoplasia (MHN) from early invasive squamous cell cancer (EISCC) of the esophagus.
Methods: Between March 2015 and January 2019, 72 study participants with MHN (n = 46) and EISCC (n = 26) of the esophagus were enrolled in this prospective study. Postoperative histopathologic analysis was the reference standard. All participants underwent MRI (T2-multi-shot turbo spin-echo sequence (msTSE), diffusion-weighted imaging (DWI), and 3D gradient-echo-based sequence (3D-GRE)). Two radiologists, blinded to participants' data, independently evaluated MRI and assigned MR features including shape (mucosal thickening or focal mass), signal on T2-msTSE and DWI, enhancement degree (intense or slight), and enhancement pattern (homogeneous, heterogeneous, or heart-shaped). Diagnostic performance of the 5 features was compared using the chi-square test; kappa values were assessed for reader performance.
Results: Surgery was performed within 3.6 + 3.5 days after MR imaging. Inter-reader agreement on MR features was excellent (kappa value = 0.854, p < 0.001). All 8 mass-like MHN were "heart-shaped" in appearance. The degree of enhancement showed the best diagnosis performance in differentiating between MHN and EISCC of the esophagus. The combination of all 5 features had only borderline improved sensitivity, specificity, and AUC of 100%, 96.2%, and 0.999, respectively, which was not statistically significant compared with the degree of enhancement alone.
Conclusions: MRI can differentiate MHN from EISCC in esophagus; the presence of "heart-shaped" appearance favors the diagnosis of MHN.
Key points: • All 8 mass-like MHN showed a "heart-shaped" enhancement pattern which may help differentiating MHN from EISCC. • Degree of enhancement had the best diagnostic performance in differentiating between MHN and EISCC in esophagus. • The combined 5 features (shape, signal in T2-msTSE and DWI, enhancement degree, and enhancement pattern) provided sensitivity, specificity, and AUC of 100%, 96.2%, and 0.999, respectively, which was not statistically significant than tumor enhancement alone in distinguishing MHN from EISCC.
Keywords: Differential diagnosis; Esophageal cancer; Magnetic resonance imaging.
References
-
- Matsubara T, Yamada K, Nakagawa A (2003) Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:4336–4341 - DOI
-
- Otowa Y, Nakamura T, Takiguchi G et al (2016) Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers. Eur J Surg Oncol 42:407–411 - DOI
-
- Chen SY, Molena D, Stem M, Mungo B, Lidor AO (2016) Post-discharge complications after esophagectomy account for high readmission rates. World J Gastroenterol 22:5246–5253 - DOI
-
- Li B, Xiang J, Zhang Y, Hu H, Sun Y, Chen H (2016) Factors affecting hospital mortality in patients with esophagogastric anastomotic leak: a retrospective study. World J Surg 40:1152–1157 - DOI
-
- Thota PN, Arora Z, Dumot JA et al (2018) Cryotherapy and radiofrequency ablation for eradication of Barrett’s esophagus with dysplasia or intramucosal cancer. Dig Dis Sci 63:1311–1319 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
